Each year, ASH is the fortunate recipient of support from throughout the corporate community. This year is no different. The Society is grateful to all those who are committed to ASH and the support of its mission.

2008 ASH Corporate Friends Program

Gold Circle Level

• Alexion Pharmaceuticals, Inc
• Amgen, Inc
• Boehringer Ingerlheim Pharmaceuticals, Inc
• Cephalon Oncology
• Eisai, Inc
• Eli Lilly & Company
• Genzyme Oncology
• Genentech BioOncology
• Gloucester Pharmaceuticals, Inc  
• Millennium Pharmaceuticals, Inc
• Novartis Oncology
• Novo, Nordisk, Inc
• Ortho BioTech Products, L.P.
• Ovation Pharmaceuticals
• Pharmion Corporation
• Roche Pharmaceuticals
• Wyeth Pharmaceuticals
  

50th Annual Meeting Supporters

• Amgen, Inc
• Boehringer Ingerlheim Pharmaceuticals, Inc
• Eli Lilly & Company
• Johnson & Johnson Pharmaceutical Research and Development, LLC
• Novartis Oncology
• Merck Oncology

Scholar Awards

• Amgen, Inc
• Millennium Pharmaceuticals, Inc

2008 Highlights of ASH Supporters

Lead Commercial Supporters

• Celgene Corporation
• GlaxoSmithKline

General Commercial Supports

• Alexion Pharmaceuticals, Inc.
• Cephalon Oncology
• Eisai, Inc
• Eli Lilly and Company
• Genentech BioOncology and Biogen Idec
• Merck Oncology
• Millennium Pharmaceuticals
• Pharmion Corporation

Supporters

• Amgen Inc.
  

Other Vital Support

Minority Medical Student Award Program (MMSAP) – Genentech BioOncology is the sole supporter of this program, committing the funds necessary to grant these awards through 2009.

Self-Assessment Program – Amgen Oncology (A complimentary copy is provided to all current U.S. and Canadian hematology, hematology-oncology, and pediatric hematology-oncology fellows.)